J Cosmet Dermatol:敏感肌,新研发的草药霜可有效减少红斑

2021-08-07 MedSci原创 MedSci原创

敏感性皮肤表现为一种综合征,表现为皮肤刺痛、烧灼和瘙痒等不适感。虽然不危及生命,但是这些不适感仍会影响患者的生活质量。虽然一些护肤品可以缓解敏感皮肤的症状,但能够改善敏感皮肤的多种异常情况的产品基本没

敏感性皮肤表现为一种综合征,表现为皮肤刺痛、烧灼和瘙痒等不适感。虽然不危及生命,但是这些不适感仍会影响患者的生活质量。虽然一些护肤品可以缓解敏感皮肤的症状,但能够改善敏感皮肤的多种异常情况的产品基本没有。

 

近日发表于J Cosmet Dermatol的一项随机双盲对照研究表明,研究人员新开发的草药霜可有效缓解敏感皮肤患者的不适症状,尤其是可有效减少红斑。

该研究共纳入35名志愿者进行此项随机双盲试验。试验面霜(A)每天两次局部涂抹在一侧面部,而对照面霜(B)则涂抹在另一侧面部。主要终点包括红斑面积、红斑指数(EI)和a*值的变化。次要终点包括经表皮失水率(TEWL)、角质层(SC)水合度和乳酸刺痛试验(LAST)得分以及L*值。基线,处理14天和28天后进行评估。

 

结果显示,使用药膏A或B治疗,受试者面部红斑面积、EI和a*值明显减少。外用药膏A或B后,TEWL和L*值也显著减少。最后,A霜组受试者的满意率高于B霜。

综上,该研究结果表明,新的草药面霜改善了敏感皮肤受试者的皮肤生物物理特性,特别是在减少红斑方面。

 

原始出处:

 

Yuanjin Zhang, et al., An herbal cream reduces erythema of sensitive skin. J Cosmet Dermatol. 2021 Mar;20(3):792-797. doi: 10.1111/jocd.13610.  

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1754688, encodeId=c8361e546880e, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Sat Jan 15 14:55:32 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896872, encodeId=8e4618968e2af, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 19 14:55:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783634, encodeId=496a1e836340a, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Fri Feb 18 22:55:32 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300480, encodeId=2c581300480ab, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436288, encodeId=91ee1436288a5, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005829, encodeId=ac0e1005829c1, content=好题目, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210807/eeb8689b59db435c9b39e0e618443f34/4a7eaee60d594312a1b1ce2da3e9c920.jpg, createdBy=276e5519530, createdName=没有背景,只有背影, createdTime=Sat Aug 07 16:22:43 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2022-01-15 zll0637
  2. [GetPortalCommentsPageByObjectIdResponse(id=1754688, encodeId=c8361e546880e, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Sat Jan 15 14:55:32 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896872, encodeId=8e4618968e2af, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 19 14:55:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783634, encodeId=496a1e836340a, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Fri Feb 18 22:55:32 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300480, encodeId=2c581300480ab, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436288, encodeId=91ee1436288a5, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005829, encodeId=ac0e1005829c1, content=好题目, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210807/eeb8689b59db435c9b39e0e618443f34/4a7eaee60d594312a1b1ce2da3e9c920.jpg, createdBy=276e5519530, createdName=没有背景,只有背影, createdTime=Sat Aug 07 16:22:43 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2022-01-19 一闲
  3. [GetPortalCommentsPageByObjectIdResponse(id=1754688, encodeId=c8361e546880e, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Sat Jan 15 14:55:32 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896872, encodeId=8e4618968e2af, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 19 14:55:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783634, encodeId=496a1e836340a, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Fri Feb 18 22:55:32 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300480, encodeId=2c581300480ab, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436288, encodeId=91ee1436288a5, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005829, encodeId=ac0e1005829c1, content=好题目, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210807/eeb8689b59db435c9b39e0e618443f34/4a7eaee60d594312a1b1ce2da3e9c920.jpg, createdBy=276e5519530, createdName=没有背景,只有背影, createdTime=Sat Aug 07 16:22:43 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2022-02-18 tcm99hq
  4. [GetPortalCommentsPageByObjectIdResponse(id=1754688, encodeId=c8361e546880e, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Sat Jan 15 14:55:32 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896872, encodeId=8e4618968e2af, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 19 14:55:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783634, encodeId=496a1e836340a, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Fri Feb 18 22:55:32 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300480, encodeId=2c581300480ab, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436288, encodeId=91ee1436288a5, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005829, encodeId=ac0e1005829c1, content=好题目, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210807/eeb8689b59db435c9b39e0e618443f34/4a7eaee60d594312a1b1ce2da3e9c920.jpg, createdBy=276e5519530, createdName=没有背景,只有背影, createdTime=Sat Aug 07 16:22:43 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2021-08-09 lqvr
  5. [GetPortalCommentsPageByObjectIdResponse(id=1754688, encodeId=c8361e546880e, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Sat Jan 15 14:55:32 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896872, encodeId=8e4618968e2af, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 19 14:55:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783634, encodeId=496a1e836340a, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Fri Feb 18 22:55:32 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300480, encodeId=2c581300480ab, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436288, encodeId=91ee1436288a5, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005829, encodeId=ac0e1005829c1, content=好题目, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210807/eeb8689b59db435c9b39e0e618443f34/4a7eaee60d594312a1b1ce2da3e9c920.jpg, createdBy=276e5519530, createdName=没有背景,只有背影, createdTime=Sat Aug 07 16:22:43 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2021-08-09 zhouqu_8
  6. [GetPortalCommentsPageByObjectIdResponse(id=1754688, encodeId=c8361e546880e, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Sat Jan 15 14:55:32 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896872, encodeId=8e4618968e2af, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jan 19 14:55:32 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783634, encodeId=496a1e836340a, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Fri Feb 18 22:55:32 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300480, encodeId=2c581300480ab, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436288, encodeId=91ee1436288a5, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Aug 09 04:55:32 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005829, encodeId=ac0e1005829c1, content=好题目, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210807/eeb8689b59db435c9b39e0e618443f34/4a7eaee60d594312a1b1ce2da3e9c920.jpg, createdBy=276e5519530, createdName=没有背景,只有背影, createdTime=Sat Aug 07 16:22:43 CST 2021, time=2021-08-07, status=1, ipAttribution=)]
    2021-08-07 没有背景,只有背影

    好题目

    0

相关资讯

NEJM:红皮病型银屑病和HIV感染-病例报道

广泛性红斑和斑块形成的鉴别诊断包括红皮病性银屑病、脂溢性皮炎和毛发糠疹。从背部两个区域获得的穿孔活检标本证实了红皮病型银屑病的诊断。红皮性丘疹鳞状喷发可能与潜在的全身性疾病有关。

12岁少女脸上长红斑 原来是一免疫疾病在捣乱!

系统性红斑狼疮(Systemic lupus erythematosus,SLE)是一种累及全身多个器官和系统的自身免疫性疾病,多见于育龄期妇女,以15~40岁多发,儿童并不少见,居小儿风湿类疾病的第2位。发病率约为25/10万,东方人和有色人种好发。国内根据对32668 人群的调查,患病率为70.42/10万,女性为113.33/10万,中国至少有100万人患SLE。

非瘢痕性红斑及紧张水疱不伴循环抗BP180抗体患者1例

患者女性,80余岁,躯干和四肢有1年瘙痒性红斑病史。局部糖皮质激素、口服罗红霉素(300 mg / d)或窄带UV-B光疗对红斑无效。该患者有2型糖尿病和高血压病史,并采用格列美脲、磷酸西格列汀和苯磺酸氨氯地平治疗。患者还患有多肌痛,采用低剂量泼尼松龙治疗。患者因肺炎入院治疗,且在就诊皮肤科前2个月停用泼尼松龙。随后患者手掌出现多个紧张水疱。首次就诊体格检查显示全身鳞状红斑,手臂、手、足底和臀部出

年轻女性持续性颧骨红斑伴萎缩1例

患者女性,21岁,无显著病史,有2年无症状、面部发红病史,阳光照射下发作。患者曾接受多西环素100 mg / d和局部磺胺醋酰治疗,但效果不佳。检查发现,患者面颊和鼻梁处存在多个环状红斑且局部萎缩。患者仅口服过避孕药。血清化学分析和全血细胞计数未见异常,抗Ro、抗La和定性ANA抗体均呈阴性。临床诊断后9个月,患者接受米诺环素、地奈德、局部甲硝唑(0.75%)、乳膏和壬二酸(15%)治疗无效,且斑

四肢网状红斑对称分布 遇冷水后加重怎么回事?

16岁女学生,四肢对称性青斑10年,无明显自觉症状。冬季及遇冷水后加重,未引起重视。您了解这种少见的血管收缩性疾病吗?

臀部弥漫性红斑,却引发了尿潴留,原因竟然是......

骶尾部带状疱疹可出现泌尿系统的并发症,尤其是老年人,自觉症状不明显,易于误诊、漏诊,看看下面这个案例~